Chemopreventive activities of etodolac and oxyphenbutazone against mouse skin carcinogenesis.
Kapadia
Govind J
GJ
Department of Pharmaceutical Sciences, School of Pharmacy, Howard University, Washington, DC 20059, USA. gkapadia@howard.edu
Azuine
Magnus A
MA
Shigeta
Yuuko
Y
Suzuki
Nobutaka
N
Tokuda
Harukuni
H
D015127:9,10-Dimethyl-1,2-benzanthracene / Q000633:toxicity; D000818:Animals; D016588:Anticarcinogenic Agents / Q000494:pharmacology*; D002273:Carcinogens / Q000633:toxicity; D002471:Cell Transformation, Neoplastic / Q000139:chemically induced / Q000187:drug effects*; D017308:Etodolac / Q000494:pharmacology*; D051379:Mice; D010113:Oxyphenbutazone / Q000494:pharmacology*; D012878:Skin Neoplasms / Q000517:prevention & control*
D016588:Anticarcinogenic Agents; D002273:Carcinogens; D017308:Etodolac; D015127:9,10-Dimethyl-1,2-benzanthracene; D010113:Oxyphenbutazone